Although our data reveal minimal CCN2 production by hepatocytes in NASH fibrosis, other studies have implicated hepatocytes instead of HSC, but this often happens during earlier non-fibrotic stages of the disease and/or in concert with other injurious pathways. The gene discussed is CCN2; the disease is metabolic dysfunction-associated steatohepatitis.